- Home
- JRVR vs INGN Comparison
JRVR vs INGN Comparison
Compare JRVR & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JRVR | INGN |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.2M | 172.4M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | JRVR | INGN |
|---|---|---|
| Price | $4.14 | $6.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $7.33 | ★ $11.25 |
| AVG Volume (30 Days) | ★ 446.5K | 335.9K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 125.82 | 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $687,614,000.00 | $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | $1.61 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $3.76 | $5.34 |
| 52 Week High | $7.20 | $9.13 |
Technical Indicators
Market Signals| Indicator | JRVR | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 20.92 | 40.34 |
| Support Level | N/A | $5.97 |
| Resistance Level | $5.61 | $6.93 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 13.35 | 6.93 |
Price Performance
Historical ComparisonAbout JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.